For general media inquiries, please contact mediainquiries@jenner.com.
News
Jenner & Block Secures Trial Victory for Chance the Rapper
News
Recognition
Jenner & Block Named Law Firm of the Year, Earned Additional Honors Across Categories by The American Lawyer 2025 Industry Awards
Recognition
Recognition
Chicago Bar Association Names Jenner & Block Law Firm of the Year
Recognition
All News and Insights
News
Jenner & Block Partner Aaron Barlow Appointed Chair of PTAB Bar Association Trial Committee
Partner Aaron A. Barlow has been appointed chair of the Patent Trial and Appeal Board Bar Association’s Trial Committee. The committee proposes responses to legislative proposals, modifications to trial rules and procedures before the PTAB, and comments on amicus briefs that implicate PTAB trials. The Association fosters constructive dialog between fellow bar members, the PTAB itself, and corporate and government stakeholders.
Publications
Jenner & Block Lawyers Author Patent Overview in Lexology’s Panoramic: Patents 2025
Partners Amr Aly and Aaron Barlow and Associate Paaras Modi provided an overview of patent law around the globe in Lexology’s Panoramic: Patents 2025. The authors addressed transformations within the patent landscape characterized by legal reform and technological advancements in North America, Europe, and Asia.
Lexology’s Panoramic: Patents 2024
Partners Amr Aly and Aaron Barlow and Associate Paaras Modi edited Lexology’s Panoramic: Patents 2024 and also wrote the chapter that provides an overview of patent law around the globe. Formerly called Getting the Deal Through, the Panoramic guide offers audiences a unique tool to compare laws and regulations across jurisdictions.
Client Alert: Supreme Court Affirms High Enablement Bar for Drug Patents
On May 18, 2023, the Supreme Court affirmed the Federal Circuit’s (CAFC) decision on enablement in Amgen Inc. v. Sanofi, 987 F.3d 1080 (CA Fed. 2021). The Court thus left in place a significant decision making it more difficult for drug companies to block competitive products that are functionally equivalent, but structurally different. In particular, the Court held that the Federal Circuit’s approach to determining enablement in functional genus claims is consistent with the statute and Supreme
